Prediction of future tau accumulation and cognitive decline in Down syndrome using plasma biomarkers

This study investigates plasma tau biomarkers as predictive tools for forecasting tau pathology progression and cognitive deterioration in individuals with Down syndrome. The research aims to identify early biological markers that could help clinicians anticipate neurodegenerative changes associated with increased Alzheimer's disease risk in this population.